EUVIMEDEUVIMED entdecken
Crossref

L26/O-126 Role of antioxidants in OAT

N. Malhotra, S. Soni

Human Reproduction · 01.07.2026 · 41 (Supplement_1)

DOI: 10.1093/humrep/deag083.126 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von N. Malhotra und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Oligo-asthenozoospermia (OAT) is an important cause of male infertility affecting 30% to 40% men, with oxidative stress (OS) being an important etiological factor1. While reactive oxygen species (ROS) are essential for sperm functions excessive ROS overwhelm endogenous antioxidant defences, leading to OS. Consequential lipid peroxidation, mitochondrial dysfunction, and sperm DNA fragmentation, ultimately compromising sperm function and semen quality resulting in impaired motility and fertilization capacity. Overall OS affects men with OAT negatively impacting outcomes1. Oxidative Stress Assessment of OS relies on biochemical assays that measure ROS, assess redox balance, or detect oxidative damage. Oxidation–reduction potential (ORP) serves as a measure of redox status, with the MiOXSYS system generating standardized sORP values. In a large multicentric study, this system identified infertile men with abnormal semen parameters with 98% sensitivity and 94% predictive value2. Antioxidant Supplementation Exogenous antioxidant (AOX) supplementation is used to augment endogenous defences against oxidative stress. Accessibility, low cost, and biological rationale, make empirical AOX therapy common practice. Of the various anti-oxidants, preferred ones including Vitamins C and E scavenge free radicals and prevent lipid peroxidation, while Coenzyme Q10 enhances mitochondrial energy production, carnitines support fatty acid transport and sperm metabolism, and N-acetylcysteine replenishes intracellular glutathione levels2. Combination therapies are often employed to achieve synergistic effects, but formulations, dosages, and regimens continue to limit interpretation of outcomes2. Clinical Outcomes Multiple systematic reviews and meta-analyses suggest that AOX therapy may improve sperm concentration, motility, and morphology3. A systematic review by Ross et al. reported improvement in sperm parameters or pregnancy outcomes in 82% of studies, with 60% demonstrating higher pregnancy rates4. Cochrane meta-analysis indicated that AOX supplementation may increase the odds of pregnancy by 3-fold and live birth by 2-fold5. Benefits are also reported in advanced sperm functions, particularly in couples undergoing IVF/ICSI. However, findings remain inconsistent, with heterogeneity in study design, patient selection, and treatment. Antioxidant Paradox and Limitations A key limitation in AOX therapy is the “antioxidant paradox” that limits indiscriminate use when excess AOX disrupt cellular signaling, impair mitochondrial activity, and paradoxically worsen sperm quality. Large trials such as the MOXI study have failed to demonstrate significant improvements in semen parameters or live birth rates, limiting empirical usage. Clinical Implications Recent approaches advocate for a more targeted strategy based on the concept of Male Oxidative Stress Infertility (MOSI)5 Assessment of biomarkers such as ORP or SDF can identify patients most likely to benefit from AOX therapy. There remains a need to better define optimal combinations and dosing. When indicated, a tailored antioxidant regimen should be prescribed for 3–6 months, corresponding to the duration of the spermatogenic cycle.

Conclusion

Antioxidant therapy holds promise as an adjunct in male infertility, but need future research with well-designed trials, standardized treatment protocols, and biomarker-driven patient selection to optimize clinical outcome References: 1. Bisht S, Faiq M, Tolahunase M, Dada R. Oxidative stress and male infertility. Nat Rev Urol. 2017; 14:470–85. 2. Bouhadana D, Godin Pagé MH, Montjean D, Bélanger MC, Benkhalifa M, Miron P, et al. The role of antioxidants in male fertility: A comprehensive review of mechanisms and clinical applications. Antioxidants (Basel). 2025;14(8):1013. 3. Ross C, Morriss A, Khairy M, Khalaf Y, Braude P, Coomarasamy A, et al. A systematic review of the effect of oral antioxidants on male infertility. Reprod Biomed Online. 2010;20(6):711–23. 4. de Ligny W, Smits RM, Mackenzie-Proctor R, Jordan V, Fleischer K, de Bruin JP, et al. Antioxidants for male subfertility. Cochrane Database Syst Rev. 2022;5:CD007411. 5. Agarwal A, Parekh N, Panner Selvam MK, Henkel R, Shah R, Homa ST, et al. Male oxidative stress infertility (MOSI): Proposed terminology and clinical practice guidelines for management of idiopathic male infertility. World J Mens Health. 2019;37(3):296–312.

Zitieren

APA

Malhotra, N., & Soni, S. (2026). L26/O-126 Role of antioxidants in OAT. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.126

Vancouver

Malhotra N, Soni S. L26/O-126 Role of antioxidants in OAT. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.126

BibTeX
@article{Malhotra2026,
  author = {Malhotra, N. and Soni, S.},
  title = {L26/O-126 Role of antioxidants in OAT},
  journal = {Human Reproduction},
  year = {2026},
  volume = {41},
  number = {Supplement_1},
  doi = {10.1093/humrep/deag083.126}
}
Kostenlos starten →